Bioverativ to purchase True North Therapeutics for $400m

Global biotechnology company Bioverativ has entered a definitive agreement to acquire US-based company True North Therapeutics for $400m.

Source: Pharmaceutical Technology - May 24, 2017 Category: Pharmaceuticals Source Type: news